| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.11 | 0.03 |